Lihua Tang Selected Research

Neoplasms (Cancer)

10/2021	A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid Tumors.
1/2021	Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma.
10/2020	Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation.
7/2020	MiR-451a restrains the growth and metastatic phenotypes of papillary thyroid carcinoma cells via inhibiting ZEB1.
1/2020	ASNEO: Identification of personalized alternative splicing based neoantigens with RNA-seq.
12/2018	Enhanced cytotoxicity and apoptosis through inhibiting autophagy in metastatic potential colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.
12/2018	LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
5/2016	Chronic Inflammation in Skin Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lihua Tang Research Topics

Disease

8	Neoplasms (Cancer) 10/2021 - 05/2016
7	Wounds and Injuries (Trauma) 05/2022 - 01/2012
3	Obesity 10/2023 - 09/2012
3	Narcolepsy 12/2021 - 07/2021
3	Cataplexy 12/2021 - 07/2021
3	Neoplasm Metastasis (Metastasis) 10/2020 - 04/2015
2	Infections 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 10/2020
2	Melanoma (Melanoma, Malignant) 04/2015 - 01/2013
2	Glucose Intolerance 09/2012 - 11/2010
2	Inflammation (Inflammations) 09/2012 - 11/2010
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2012 - 05/2011
1	Diabetes Mellitus 01/2024
1	Overweight 10/2023
1	Endotoxemia 10/2023
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2023
1	Insulin Resistance 10/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2023
1	Epilepsy (Aura) 04/2023
1	Stroke (Strokes) 04/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Pain (Aches) 11/2022
1	Rupture 11/2022
1	Threatened Abortion 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Cholangiocarcinoma 01/2021
1	Adenocarcinoma 01/2021
1	Rheumatoid Arthritis 01/2020
1	Experimental Arthritis 01/2020
1	Nasopharyngeal Carcinoma 12/2018
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Homozygous Familial Hypercholesterolemia 01/2018
1	Carcinogenesis 02/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Xanthomatosis (Xanthoma) 01/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2009
6	SuspensionsIBA 05/2022 - 10/2020
4	CalciumIBA 12/2021 - 10/2020
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2010
3	SodiumIBA 12/2021 - 07/2021
3	MagnesiumIBA 12/2021 - 07/2021
3	PotassiumIBA 12/2021 - 07/2021
3	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2021 - 07/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2021
2	antineoplaston A10 (A 10)IBA 03/2022 - 02/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2020 - 10/2020
2	Nifedipine (Adalat)FDA LinkGeneric 12/2020 - 10/2020
2	LDL CholesterolIBA 01/2018 - 01/2017
2	LDL Receptors (LDL Receptor)IBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 02/2013 - 09/2012
2	AntigensIBA 02/2013 - 11/2010
2	Coal (Coals)IBA 01/2012 - 05/2011
1	IonsIBA 01/2024
1	MetalsIBA 01/2024
1	phenolic acidIBA 01/2024
1	Polysaccharides (Glycans)IBA 10/2023
1	chaihu-longgu-muli decoctionIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	VaccinesIBA 01/2023
1	Sialic AcidsIBA 01/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Progesterone FDA LinkGeneric 11/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2022
1	SolventsIBA 11/2022
1	Polysorbates (PSML)FDA Link 03/2022
1	Streptozocin (Streptozotocin)FDA Link 02/2022
1	Ursolic AcidIBA 02/2022
1	GSK2849330IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Neuregulin-1 (Neuregulin 1)IBA 10/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Thrombopoietin (c-mpl Ligand)IBA 01/2021
1	B7-H1 AntigenIBA 10/2020
1	Calcium Channels (Calcium Channel)IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 07/2020
1	HydrogelsIBA 01/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	GelsIBA 01/2020
1	phytochlorinIBA 12/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2018
1	Proprotein Convertase 9IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	evolocumabIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	tanshinoneIBA 02/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017

Therapy/Procedure

4	Therapeutics 10/2020 - 04/2015
3	Immunotherapy 10/2020 - 05/2016
1	Fecal Microbiota Transplantation 10/2023
1	Transjugular Intrahepatic Portasystemic Shunt 03/2022
1	Precision Medicine 01/2022
1	Intra-Articular Injections 01/2020
1	Photochemotherapy (Photodynamic Therapy) 12/2018